Aegon Ltd. vs Boston Scientific Corporation — how do they compare? Aegon Ltd. trades at $9.43 (market cap $14.01B), while Boston Scientific Corporation trades at $50.44 (market cap $74.19B). The key difference: Boston Scientific Corporation is far larger — about 5.3× Aegon Ltd.'s market cap, and Aegon Ltd. pays a 4.94% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| AEG | BSX | |
|---|---|---|
Market Cap | $14.01B | $74.19B |
Sector | Financials | Health |
52-Week High | $9.53 | $108.14 |
52-Week Low | $6.79 | $42.63 |
Enterprise Value | $15.16B | $86.27B |
Dividend Yield | 4.94% | — |
Signals from Pluang's Aura AI — not financial advice
AEG trades at $9.45, down 0.84% today, with a bullish technical signal from moving averages but neutral oscillators. Recent earnings show mixed results, beating estimates in Q2 and Q3 2025 but missing in Q4. The company maintains a P/E of 13.54 and P/S of 0.57, indicating potential undervaluation, while a strategic shift to U.S. focus and a $0.25 dividend highlight corporate stability.
The outlook is cautiously optimistic, supported by deleveraging trends and revenue growth projections to $26.9B in 2025. Risks include volatile cash flows and competitive pressures, but analyst consensus leans hold with 50% rating, suggesting steady performance amid transformation efforts.
BSX trades at $50.46, up 2.33% today, with strong earnings beats in recent quarters and a bullish technical trend. Revenue grew to $20.07B in 2025, with net income margin expanding to 17.5%. The stock shows robust institutional support and insider buying, while facing near-term headwinds from competitive pressures in key segments like WATCHMAN.
Outlook remains positive with 86% analyst buy ratings and a $67.21 consensus price target, implying 33% upside. Risks include guidance cuts and market share losses, but solid cash flow and valuation metrics support long-term growth potential for patient investors.
Trailing returns across standard periods
Latest headlines on both assets
Aegon is a Netherlands-headquartered insurance company with core operations that stretch across the U.S., Netherlands, and United Kingdom. The business also holds peripheral ventures in Spain, Portugal, Brazil, and China.
Read more on AEG →Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →